- Home
- HRB vs RVMD Comparison
HRB vs RVMD Comparison
Compare HRB & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRB
- RVMD
- Stock Information
- Founded
- HRB 1955
- RVMD 2014
- Country
- HRB United States
- RVMD United States
- Employees
- HRB N/A
- RVMD N/A
- Industry
- HRB Other Consumer Services
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HRB Consumer Discretionary
- RVMD Health Care
- Exchange
- HRB Nasdaq
- RVMD Nasdaq
- Market Cap
- HRB 8.3B
- RVMD 9.5B
- IPO Year
- HRB N/A
- RVMD 2020
- Fundamental
- Price
- HRB $58.15
- RVMD $48.23
- Analyst Decision
- HRB Sell
- RVMD Strong Buy
- Analyst Count
- HRB 2
- RVMD 13
- Target Price
- HRB $57.00
- RVMD $62.00
- AVG Volume (30 Days)
- HRB 1.7M
- RVMD 1.6M
- Earning Date
- HRB 11-07-2024
- RVMD 11-06-2024
- Dividend Yield
- HRB 2.58%
- RVMD N/A
- EPS Growth
- HRB 13.55
- RVMD N/A
- EPS
- HRB 4.11
- RVMD N/A
- Revenue
- HRB $3,620,357,000.00
- RVMD $742,000.00
- Revenue This Year
- HRB $4.03
- RVMD N/A
- Revenue Next Year
- HRB $2.61
- RVMD $299.87
- P/E Ratio
- HRB $14.13
- RVMD N/A
- Revenue Growth
- HRB 4.15
- RVMD N/A
- 52 Week Low
- HRB $42.28
- RVMD $23.38
- 52 Week High
- HRB $68.45
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- HRB 43.91
- RVMD 33.32
- Support Level
- HRB $58.57
- RVMD $56.39
- Resistance Level
- HRB $60.31
- RVMD $59.35
- Average True Range (ATR)
- HRB 1.49
- RVMD 2.23
- MACD
- HRB 0.08
- RVMD -1.13
- Stochastic Oscillator
- HRB 53.77
- RVMD 3.14
About HRB H&R Block Inc.
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public primarily in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives most of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively significant.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.